Biological Coprocessors is conducting technology research and commercialization to develop analytical applications that detect brain pathology and augment cognitive performance. For example, in collaboration with the University of Oxford in the U.K., we have uniquely identified an objective brain wave signature for pain patients.
We are currently conducting human clinical trials to validate the detection of the signature using low cost, non-invasive methods of measuring brain wave patterns. Additionally, we are testing the viability of Transcranial Direct Current Stimulation (tDCS) to manage and reduce the pain level by normalizing the defective brain wave patterns. We are also working on diagnostic and treatment tools for a range of other brain-related ailments including PTSD, Alzheimer's disease, Parkinson's disease, and others.